Top Banner
Autonomics Autonomics Claro M. Isidro M.D.
46
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Autonomics Parasympathetic

AutonomicsAutonomics

Claro M. Isidro M.D.

Page 2: Autonomics Parasympathetic

Parasympathetic DrugsParasympathetic Drugs

Drugs Affecting the ANS:

1.Cholinergic drugs – act on the receptor that is activated by acetylcholine

2.Adrenergic drugs – acts on the receptor that are stimulated by norepinephrine or epinephrine

Page 3: Autonomics Parasympathetic

Cholinergic NeuronsCholinergic Neurons

Preganglionic fibers terminating in the adrenal medulla

Preganglionic fibers of both parasympathetic & sympathetic nervous system

Postganglionic fibers of the parasympathetic nervous system

Voluntary muscles of the somatic nervous system

Page 4: Autonomics Parasympathetic
Page 5: Autonomics Parasympathetic
Page 6: Autonomics Parasympathetic

Neurotransmission at Cholinergic neurons

Synthesis of acetylcholineStorage of acetylcholine in vesiclesRelease of acetylcholineBinding to receptorDegradation of acetylcholineRecycling of choline

Page 7: Autonomics Parasympathetic

Cholinergic Receptors Muscarinic : M1 – nerves M2 – heart, nerves, smooth muscles M3 – glands, smooth muscles Endothelium M4 - ? CNS M5 - ? CNS

Nicotinic: Nm – skeletal muscles Neuromuscular junction Nn – Preganglionic parasympathetic & sympathetic

Page 8: Autonomics Parasympathetic
Page 9: Autonomics Parasympathetic

Effector Organs Receptors Action

Eye sphincter m.

ciliary m.

M3

M3

Contraction (meiosis)Contraction(accomodation)

Heart SA node AV node Contractility

M2

M2

M2

↓ Heart rate

↓ conduction velocity & ↑ refractory period

↓ contraction

Lung bronchial m. M3 contraction

Page 10: Autonomics Parasympathetic

Effector Organs Receptor Action

Blood Vessels most BV skeletal m.

--

Small doses – vasodilatation Large doses – vasoconstriction

GIT sphincter motility & tone

M3

M3

RelaxationIncrease

GUT trigone & sphincter m. bladder wall & detrusor m.Penis, seminal v.

M3

M3

M

Relaxation

Contraction

Erection

Page 11: Autonomics Parasympathetic

Effector Organs

Receptor Action

Secretory glands sweat intestinal bronchial lacrimal

M

M3

MM

Generalized secretion↑ secretion↑ secretionProfuse secretion

Page 12: Autonomics Parasympathetic

Cholinomimetics / Parasympathetic Agonist/Cholinergic Agonist Drugs that have effects producing parasympathetic dominance

Direct-Acting Cholinoceptor Stimulants

A. Esters of Choline: Synthetic

1. Acetylcholine 3. Carbachol

2. Metacholine 4. Betanechol

B. Alkaloids: Naturally occurring

1. Muscarinic

Muscarine, Pilocarpine, Oxotremorine

2. Nicotinic

Nicotine, Lobeline,

Dimethylphenylpiperazinium (DMPP)

Page 13: Autonomics Parasympathetic

Direct-Acting (Choline Esters)::

Acetylcholine quarternary ammonium compound muscarinic & nicotinic receptors equally Actions:

↓ HR and CO, ↓ BP ↑ salivary & intestinal secretion and GI motility Enhances bronchiolar secretions ↑ detrussor muscle tone stim. Ciliary m. → near vision miosis

Page 14: Autonomics Parasympathetic

Susceptibility to

Cholinesterase

Muscarinic Effects

Nicotinic Effects

Therapeutic Use

Ach + +++ +++ Miotic

Metacholine

+ ++++ + Dx of bronchial hyperactivity

Carbachol - +++ ++ Miotic

Betanechol - ++ - Non-obstructive urinary retention

Page 15: Autonomics Parasympathetic

Direct-Acting (Choline Esters):

Naturally-occurring:

Pilocarpine• tertiary amine

• dominant muscarinic action• resistant to acetylcholinesterase• Use as topical eye drop. Produce rapid meiosis & contraction of

ciliary muscle• Increase gastric acid secretion & bronchoconstiction• Potent stimulator of secretions (sweat, tears, saliva)• Therapeutic Use:

• DOC in emergency lowering of IOP in glaucoma• Adverse Effects: CNS disturbances, profuse sweating and salivation

Page 16: Autonomics Parasympathetic

ARECOLINE• chief alkaloid of areca or betel nuts• muscarinic & nicotinic receptors• enhances salivary secretion• no therapeutic indication

MUSCARINE• quarternary amine• muscarinic receptors• found in mushrooms (Amanita muscaria)• small amounts edible• large amounts poisonous• effects: fall in BP, temporary cessation of heart beat,

diaphoresis• antidote: ATROPINE

Page 17: Autonomics Parasympathetic

Indirect-Acting : AnticholinesteraseIndirect-Acting : Anticholinesterase

REVERSIBLE (Anticholinesterases)

IRREVERSIBLE (Organophosphate)

Page 18: Autonomics Parasympathetic

AnticholinesteraseAnticholinesterase

AcetylCholine Choline + Acetic acid

Cholinesterase-

Page 19: Autonomics Parasympathetic

Indirect-Acting :REVERSIBLE (Anticholinesterases):

Physostigmine Neostigmine Pyridostigmine Ambenonium Edrophonium Tacrine, Donezepil, Rivastigmine, Galantamine

IRREVERSIBLE1. Organophosphates

• Isoflurophate• Echothiophate• Malathion, Parathion

2. Chemical Warfares• Sarin, Soman

Page 20: Autonomics Parasympathetic

PHYSOSTIGMINE• Alkaloid, tertiary ammmonium grp.• Enters the CNS• DOA: O.5 to 2 hrs.• Therapeutic Uses:

1. Atony of intestines and bladder2. Glaucoma lowers IOP3. Antidote atropine, phenothiazines, TCA4. NDMR (tubocurarine) reversal

• Adverse effects: convulsions, bradycardia, CO

Page 21: Autonomics Parasympathetic

NEOSTIGMINE• Quarternary ammonium grp.• Does not enter the CNS peripheral• DOA: 0.5 to 2 hrs• Therapeutic Uses:

1. Atony of intestines and bladder2. Myasthenia gravis3. NDMR (tubocurarine) antidote

• Adverse effects: salivation, flushing, ↓ BP, nausea, abdominal pain, diarrhea, bronchospasm

Page 22: Autonomics Parasympathetic

PYRIDOSTIGMINE and AMBENONIUM

• DOA: PYRIDOSTIGMINE - 3 to 6 hrs• AMBENONIUM – 4 to 8 hrs• Therapeutic Uses:

1. Myasthenia gravis2. NDMR (tubocurarine) antidote

• Adverse effects: salivation, flushing, ↓ BP, nausea, abdominal pain, diarrhea, bronchospasm

Page 23: Autonomics Parasympathetic

EDROPHONIUM • Quarternary amine• DOA: 5 to 15 mins• Therapeutic Uses:

1. Diagnosis of Myasthenia gravis2. NDMR (tubocurarine) antidote3. Arrhythmias (SVT)

• Antidote: Atropine• Adverse effects: salivation, flushing, ↓ BP, nausea,

abdominal pain, diarrhea, bronchospasm

Page 24: Autonomics Parasympathetic

Tacrine, Donezepil, Rivastigmine,Galantamine

• Alzheimer disease deficiency of cholinergic neurons in the CNS

• Tacrine – hepatotoxic• Adverse effect: GI distress

Page 25: Autonomics Parasympathetic

Indirect-Acting IRREVERSIBLE : ORGANOPHOSPHATES

ISOFLUROPHATE tx of open angle glaucoma

ECHOTHIOPHATE Produce intense miosis tx of open angle glaucoma

PARATHION, MALATHION Insecticides

Page 26: Autonomics Parasympathetic

ORGANOPHOSPHATE POISONING:

Signs & Symptoms1. miosis2. salivation, frothy secretions3. sweating4. bronchial constriction5. vomiting and diarrhea6. muscle fasciculation

Page 27: Autonomics Parasympathetic

ORGANOPHOSPHATE POISONING:

Therapy:• maintenance of VS respiration• Decontamination• Drugs: Atropine + Pralidoxime ATROPINE sulfate

• 1 to 2 mg IV every 5-15 min until muscarinic effect disappears (maximum of 1 gm per day)

PRALIDOXIME

• A cholinesterase enzyme regenerator compound

• - 1 to 2 gm given over 30 min by IV infusion

Page 28: Autonomics Parasympathetic
Page 29: Autonomics Parasympathetic

Parasympathetic Antagonists/Cholinergic Antagonist (Parasympatholytics)

ANTIMUSCARINIC

Tertiary Amines:a. Natural – atropine, scopolamine

b. Semisynthetic – tropine, homatropine

c. Synthetic – dicyclomine, oxybutyrine, oxyphencyclimine

Quarternary Amines:a. Anisotropine

b. Propantheline

c. Methanteline

Page 30: Autonomics Parasympathetic
Page 31: Autonomics Parasympathetic

ATROPINE• prototype• Belladona alkaloid• high affinity for muscarinic receptors• central and peripheral muscarinic blocker

causes reversible (surmountable) blockade of the actions of cholinomimetics at muscarinic receptors

Unopposed sympathetic action

Page 32: Autonomics Parasympathetic

ATROPINEActions:1. CNS

• minimal stimulant effect2. Eye

• mydriasis, unresponsiveness to light• cycloplegia inability to focus for near-vision

3. GIT• antispasmodic reduce GIT activity

4. GUT • reduce urinary bladder hypermotility

5. SECRETIONS• blocks salivary glands antisialogogue• decrease also lacrimal & sweat glands secretion

Page 33: Autonomics Parasympathetic

ATROPINE

6. CVSdivergent effects depending on

dose

Low dose – (-) M1 ↑ Ach release

Higher dose – (-) M2 on SA node ↑ CR

Page 34: Autonomics Parasympathetic

Effects in relation to dose:

Dose Effects

0.5 mg Slight cardiac slowing some dryness of mouth inhibition of sweating

1.0 mg Definite dryness of mouth; thirst acceleration of heart, sometimes preceded by slowingmild pupillodilatation

Page 35: Autonomics Parasympathetic

Dose Effects

2.0 mg Rapid HR; palpitations marked dryness of mouth Dilated pupils; some blurring of vision

5.0 mg All of the above symptoms marked; difficulty in speaking and swallowing;Restlessness and fatigue;Headache; dry, hot skinDifficulty in micturitionReduced intestinal peristalsis

Page 36: Autonomics Parasympathetic

Dose Effects

10.0 mg and more Above symptoms more markedPulse rapid and weakIris practically obliteratedVision very blurredSkin flushed, hot, dry, and scarletAtaxia, restlessness and excitementHallucinations and deliriumComa

Page 37: Autonomics Parasympathetic

ATROPINETherapeutic Uses:1. Ophthalmic

• Permits measurement of EOR

2. Antispasmodic3. Antidote for cholinergic agonists

• Organophosphate poisoning• Mushroom poisoning• acetylcholinesterase inhibitors

4. Antisecretory agent

Page 38: Autonomics Parasympathetic

SCOPOLAMINE• Belladona alkaloid• Peripheral effects similar to atropine• Greater and longer CNS action• Action:

• Anti-motion sickness• Blocks short-term memory• Produces sedation, • excitement

Page 39: Autonomics Parasympathetic

Therapeutic Uses: anti-motion sickness adjunct in anesthesia procedures > in obstetrics, + morphine sedation & amnesia

IPRATROPIUM• Quarternary derivative of atropine• Does not enter CNS • Therapeutic Uses:

• Treat asthma in patients who are unable to take adrenergic agonists

• Management of COPD

Page 40: Autonomics Parasympathetic

GANGLIONIC BLOCKERS

Specifically act on NICOTINIC receptors No selectivity towards PNS or SNS Blocks entire ANS output

Page 41: Autonomics Parasympathetic

GANGLIONIC BLOCKERSA. NICOTINE

B. TRIMETHAPHAN

C. MECAMYLAMINE

D. HEXAMETHONIUM

Page 42: Autonomics Parasympathetic
Page 43: Autonomics Parasympathetic

The End

Page 44: Autonomics Parasympathetic

Write A if cholinergic agonist

B if cholinergic antagonist

1. Bethanicol

2. Scopolamine

3. Isoflurophate

4. Trimethaphan

5. Arecoline

6. Main neurotransmitter of PNS

7. Amino acid precursor of Ach

8. Drug of choice in emergency lowering of IOP

9. Antidote for organophosphate poisoning

10. Aids in the diagnosis of myasthenia gravis

Page 45: Autonomics Parasympathetic

Short QuizShort Quiz

1. Describe the pharmacodynamic difference between direct and indirect acting cholinomimetics

2. Describe the effects of acetylcholine on the major organs

3. Describe the effects of atropine on the major organ system

4. Clinical uses of atropine & scopolamine

Page 46: Autonomics Parasympathetic

A. NICOTINE Low dose :

ganglionic stimulation by depolarization CNS: euphoria, arousal, relaxation

improves attention, learning, problem solving & reaction time

Peripheral: ↑ BP & HR, vasoconstriction

High dose ganglionic blockade BP falls, blocks GIT & bladder activity